000503.SZ

China Reform Health Management and Services Group Co., Ltd. 000503.SZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 000503.SZ 300244.SZ 600587.SS 688658.SS 603108.SS 000950.SZ 688105.SS 688319.SS 002332.SZ 688656.SS
6M -5.48 % 12.58 % 5.55 % 24.99 % -12.87 % 9.84 % -0.49 % 47.88 % 4.02 % 61.30 %
YTD -6.29 % 40.22 % -0.19 % 50.49 % -4.40 % 1.90 % 3.65 % 116.54 % -1.24 % 63.54 %
1Y -33.51 % 18.17 % -12.59 % -8.17 % -17.40 % -4.63 % -11.85 % 106.64 % -29.09 % 373.07 %
3Y -5.38 % -48.18 % -22.67 % 19.09 % 36.92 % 8.28 % -65.84 % 45.82 % -9.88 % 318.26 %
5Y -5.38 % -60.51 % 26.82 % -32.17 % 8.05 % 2.29 % -73.68 % -42.26 % -36.30 % 136.91 %
10Y -71.87 % -67.18 % -50.57 % -32.17 % -1.67 % -18.17 % -73.68 % -42.26 % 7.16 % 136.91 %
From the beginning 578.08 % 243.24 % 200.00 % -32.17 % 225.83 % -6.29 % -73.68 % -42.26 % 7.64 % 136.91 %

Dividend

China Reform Health Management and Services Group Co., Ltd.

Dian Diagnostics Group Co.,Ltd.

Shinva Medical Instrument Co., Ltd.

Youcare Pharmaceutical Group Co., Ltd.

Shanghai Runda Medical Technology Co., Ltd.

C.Q. Pharmaceutical Holding Co., Ltd.

Nanjing Vazyme Biotech Co., Ltd.

Chengdu Olymvax Biopharmaceuticals Inc.

Zhejiang Xianju Pharmaceutical Co.,Ltd.

HOB Biotech Group Corp.,Ltd